ClearArc Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,673
Closed -$961K 357
2019
Q3
$961K Buy
9,673
+72
+0.7% +$6.84K 0.28% 85
2019
Q2
$888K Sell
9,601
-1,221
-11% -$116K 0.26% 93
2019
Q1
$1.02M Sell
10,822
-268
-2% -$23.4K 0.27% 87
2018
Q4
$711K Sell
11,090
-5,188
-32% -$383K 0.21% 113
2018
Q3
$1.46M Buy
16,278
+84
+0.5% +$7.42K 0.19% 122
2018
Q2
$1.29M Sell
16,194
-921
-5% -$76.5K 0.18% 128
2018
Q1
$1.53M Sell
17,115
-798
-4% -$76.6K 0.23% 105
2017
Q4
$1.87M Buy
17,913
+181
+1% +$20.4K 0.25% 91
2017
Q3
$2.59M Buy
17,732
+35
+0.2% +$4.77K 0.39% 63
2017
Q2
$2.3M Buy
17,697
+97
+0.6% +$11.9K 0.37% 64
2017
Q1
$2.19M Buy
17,600
+186
+1% +$22.3K 0.36% 67
2016
Q4
$2.02M Sell
17,414
-191
-1% -$21.3K 0.36% 72
2016
Q3
$1.84M Sell
17,605
-1,204
-6% -$130K 0.35% 69
2016
Q2
$1.85M Sell
18,809
-268
-1% -$27.7K 0.36% 70
2016
Q1
$1.91M Sell
19,077
-134
-0.7% -$13.8K 0.4% 60
2015
Q4
$2.3M Sell
19,211
-193
-1% -$22.3K 0.48% 50
2015
Q3
$2.1M Sell
19,404
-226
-1% -$28K 0.44% 56
2015
Q2
$2.27M Sell
19,630
-3,610
-16% -$413K 0.42% 57
2015
Q1
$2.68M Buy
23,240
+5,318
+30% +$635K 0.55% 46
2014
Q4
$2M Buy
17,922
+1,113
+7% +$117K 0.41% 66
2014
Q3
$1.59M Buy
16,809
+707
+4% +$63.8K 0.36% 81
2014
Q2
$1.38M Sell
16,102
-494
-3% -$37.6K 0.32% 93
2014
Q1
$1.16M Buy
16,596
+390
+2% +$30.9K 0.29% 100
2013
Q4
$1.37M Sell
16,206
-822
-5% -$65K 0.35% 86
2013
Q3
$1.31M Buy
17,028
+1,008
+6% +$70.6K 0.37% 76
2013
Q2
$937K Buy
+16,020
New +$964K 0.25% 119

Other funds holding CELG

ClearArc Capital's CELG Position: Q4 2019 in Review

ClearArc Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,673 shares — an estimated $961K sold.

ClearArc Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.68M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ClearArc Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ClearArc Capital sold 9,673 Celgene Corp shares in Q4 2019, an estimated $961K.
  • ClearArc Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ClearArc Capital's Celgene Corp position peaked at $2.68M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.